The Latest in CLL

CAR T-cell start-up launched

May 10, 2016

CLL

‘Universal’ CAR T cell may overcome limitations

April 28, 2016

CLL

New single-tube assay detects one CLL cell in 1 million leukocytes

April 27, 2016

CLL

VP Biden to AACR: Help me help you

April 21, 2016

CLL

In newly diagnosed CLL, mutation tests are advised

April 13, 2016

CLL

FDA approves venetoclax for CLL with 17p deletion

April 11, 2016

CLL

Feds advance cancer moonshot with expert panel, outline of goals

April 5, 2016

CLL

RPS15 mutations prevalent in aggressive chronic lymphocytic leukemia

March 16, 2016

CLL

Idelalisib use halted in six combo therapy trials, FDA announces

March 15, 2016

Ibrutinib approved as first-line therapy for all CLL patients

March 7, 2016

CLL

Venetoclax shows promise for relapsed CLL, SLL

February 4, 2016

CLL

Acalabrutinib yields 95% overall response in relapsed CLL

January 27, 2016

CLL

Ofatumumab approved for extended treatment of CLL patients in complete or partial response

January 19, 2016

CLL

Venetoclax gets 79% overall response rate in high-risk CLL

January 13, 2016

CLL

Ibrutinib response durable at 1 year in CLL patients who relapsed after allogeneic stem cell transplants

January 13, 2016

CLL